491 related articles for article (PubMed ID: 30244071)
21. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
[TBL] [Abstract][Full Text] [Related]
22. Influence of extracellular K+ concentration on the time-course of Na+/K+-ATPase inhibition by cardiac glycosides with fast and low binding kinetics.
Gleitz J; Peters M
Eur J Pharmacol; 1997 Sep; 335(1):89-97. PubMed ID: 9371549
[TBL] [Abstract][Full Text] [Related]
23. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
[TBL] [Abstract][Full Text] [Related]
24. Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1.
Hauck C; Potter T; Bartz M; Wittwer T; Wahlers T; Mehlhorn U; Scheiner-Bobis G; McDonough AA; Bloch W; Schwinger RH; Müller-Ehmsen J
Eur J Pharmacol; 2009 Nov; 622(1-3):7-14. PubMed ID: 19751721
[TBL] [Abstract][Full Text] [Related]
25. Depth of the Steroid Core Location Determines the Mode of Na,K-ATPase Inhibition by Cardiotonic Steroids.
Tverskoi AM; Poluektov YM; Klimanova EA; Mitkevich VA; Makarov AA; Orlov SN; Petrushanko IY; Lopina OD
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948068
[TBL] [Abstract][Full Text] [Related]
26. Influence of 16 beta formylation on Na, K-ATPase inhibition by cardiac glycosides.
De Pover A; Godfraind T
Naunyn Schmiedebergs Arch Pharmacol; 1982 Nov; 321(2):135-9. PubMed ID: 6296702
[TBL] [Abstract][Full Text] [Related]
27. Cardenolide aglycones inhibit tumor necrosis factor α-induced expression of intercellular adhesion molecule-1 at the translation step by blocking Na⁺/K⁺-ATPase.
Okina Y; Takeuchi F; Yokomichi T; Takada Y; Kataoka T
Biol Pharm Bull; 2015; 38(1):39-47. PubMed ID: 25744456
[TBL] [Abstract][Full Text] [Related]
28. Effect of sugar positions in ginsenosides and their inhibitory potency on Na+/K+-ATPase activity.
Chen RJ; Chung TY; Li FY; Lin NH; Tzen JT
Acta Pharmacol Sin; 2009 Jan; 30(1):61-9. PubMed ID: 19060914
[TBL] [Abstract][Full Text] [Related]
29. Cardiotonic steroid-resistant alpha1-Na+,K+-ATPase rescues renal epithelial cells from the cytotoxic action of ouabain: evidence for a Nai+,Ki+ -independent mechanism.
Akimova OA; Tremblay J; Van Huysse JW; Hamet P; Orlov SN
Apoptosis; 2010 Jan; 15(1):55-62. PubMed ID: 19949978
[TBL] [Abstract][Full Text] [Related]
30. Magnesium lithospermate B possesses inhibitory activity on Na+,K+-ATPase and neuroprotective effects against ischemic stroke.
Tzen JT; Jinn TR; Chen YC; Li FY; Cheng FC; Shi LS; She HKh; Chen BC; Hsieh V; Tu ML
Acta Pharmacol Sin; 2007 May; 28(5):609-15. PubMed ID: 17439716
[TBL] [Abstract][Full Text] [Related]
31. Antagonism by potassium of the inhibition of (Na(+)+K+) ATPase produced by an endogenous digitalis-like compound extracted from mammalian heart.
Castañeda-Hernández G; Flores-Murrieta FJ
Arch Med Res; 1992; 23(1):13-7. PubMed ID: 1339224
[TBL] [Abstract][Full Text] [Related]
32. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.
Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI
Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136
[TBL] [Abstract][Full Text] [Related]
33. Na,K-ATPase activity modulates Src activation: a role for ATP/ADP ratio.
Weigand KM; Swarts HG; Fedosova NU; Russel FG; Koenderink JB
Biochim Biophys Acta; 2012 May; 1818(5):1269-73. PubMed ID: 22290188
[TBL] [Abstract][Full Text] [Related]
34. Involvement of the sugar moiety in the inhibitory action of the cardiac glycosides on the palytoxin-induced responses in vascular smooth muscles.
Ozaki H; Nagase H; Urakawa N
J Pharmacol Exp Ther; 1984 Oct; 231(1):153-8. PubMed ID: 6149301
[TBL] [Abstract][Full Text] [Related]
35. Quantification of the total Na,K-ATPase concentration in atria and ventricles from mammalian species by measuring 3H-ouabain binding to intact myocardial samples. Stability to short term ischemia reperfusion.
Schmidt TA; Svendsen JH; Haunsø S; Kjeldsen K
Basic Res Cardiol; 1990; 85(4):411-27. PubMed ID: 2173546
[TBL] [Abstract][Full Text] [Related]
36. Fluoresceinyl-ethylenediamine-ouabain detects an acidic environment in the cardiac glycoside binding site of Na+/K+-ATPase.
Brinkmann K; Linnertz H; Amler E; Lanz E; Herman P; Schoner W
Eur J Biochem; 1997 Oct; 249(1):301-8. PubMed ID: 9363783
[TBL] [Abstract][Full Text] [Related]
37. Cardiac glycoside activities link Na(+)/K(+) ATPase ion-transport to breast cancer cell migration via correlative SAR.
Magpusao AN; Omolloh G; Johnson J; Gascón J; Peczuh MW; Fenteany G
ACS Chem Biol; 2015 Feb; 10(2):561-9. PubMed ID: 25334087
[TBL] [Abstract][Full Text] [Related]
38. Effects of vanadate on ouabain binding and inhibition of (Na+ + K+)-ATPase.
Myers TD; Boerth RC; Post RL
Biochim Biophys Acta; 1979 Nov; 558(1):99-107. PubMed ID: 227460
[TBL] [Abstract][Full Text] [Related]
39. [The calixarenes C-97 and C-107 stimulate influence of ouabain on the Na+,K+-ATPase activity in plasmatic membrane of smooth muscle cells].
Veklich TO; Shkrabak OA; Kosterin SO; Rodik RV; Cherenok SO; Boĭko SO; Boĭko VI; Kal'chenko VI
Ukr Biokhim Zh (1999); 2006; 78(6):53-63. PubMed ID: 17494319
[TBL] [Abstract][Full Text] [Related]
40. Synergistic interaction between ouabain and 8-methoxy-3,9-dihydroxy coumestan, a non-steroidal synthetic inhibitor of Na+,K+-ATPase.
Pôças ES; Touza NA; da Silva AJ; Costa PR; Noël F
Life Sci; 2007 Sep; 81(15):1199-204. PubMed ID: 17884104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
